BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

20 related articles for article (PubMed ID: 9526840)

  • 1. The effect of systemic inflammation on human brain barrier function.
    Elwood E; Lim Z; Naveed H; Galea I
    Brain Behav Immun; 2017 May; 62():35-40. PubMed ID: 27810376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid secretory Ca2+-dependent phospholipase A2 activity: a biomarker of blood-cerebrospinal fluid barrier permeability.
    Chalbot S; Zetterberg H; Blennow K; Fladby T; Grundke-Iqbal I; Iqbal K
    Neurosci Lett; 2010 Jul; 478(3):179-83. PubMed ID: 20470866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and pathogenesis of clinical relapse after herpes simplex encephalitis in adults.
    Sköldenberg B; Aurelius E; Hjalmarsson A; Sabri F; Forsgren M; Andersson B; Linde A; Strannegård O; Studahl M; Hagberg L; Rosengren L
    J Neurol; 2006 Feb; 253(2):163-70. PubMed ID: 16222428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential induction of apoptosis in demyelinating and nondemyelinating infection by mouse hepatitis virus.
    Schwartz T; Fu L; Lavi E
    J Neurovirol; 2002 Oct; 8(5):392-9. PubMed ID: 12402165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged intrathecal release of soluble Fas following severe traumatic brain injury in humans.
    Lenzlinger PM; Marx A; Trentz O; Kossmann T; Morganti-Kossmann MC
    J Neuroimmunol; 2002 Jan; 122(1-2):167-74. PubMed ID: 11777556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum and cerebrospinal fluid soluble Fas levels in clinical subgroups of multiple sclerosis.
    Boylan MT; Crockard AD; McDonnell GV; McMillan SA; Hawkins SA
    Immunol Lett; 2001 Oct; 78(3):183-7. PubMed ID: 11578693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of the soluble form of the Fas molecule in patients with multiple sclerosis and human T-lymphotropic virus type I-associated myelopathy.
    Inoue A; Koh CS; Sakai T; Yamazaki M; Yanagisawa N; Usuku K; Osame M
    J Neuroimmunol; 1997 May; 75(1-2):141-6. PubMed ID: 9143247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Level of sFas/APO 1 in serum and cerebrospinal fluid in multiple sclerosis.
    Mahovic D; Petravic D; Petelin Z; Zurak N; Horvat G; Hajnsek S
    Clin Neurol Neurosurg; 2004 Jun; 106(3):230-2. PubMed ID: 15177773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathecal expression of proteins regulating apoptosis in acute stroke.
    Tarkowski E; Rosengren L; Blomstrand C; Jensen C; Ekholm S; Tarkowski A
    Stroke; 1999 Feb; 30(2):321-7. PubMed ID: 9933267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF soluble Fas correlates with the severity of HIV-associated dementia.
    Towfighi A; Skolasky RL; St Hillaire C; Conant K; McArthur JC
    Neurology; 2004 Feb; 62(4):654-6. PubMed ID: 14981191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble Fas (Apo-1) levels in cerebrospinal fluid of multiple sclerosis patients.
    Ciusani E; Frigerio S; Gelati M; Corsini E; Dufour A; Nespolo A; La Mantia L; Milanese C; Massa G; Salmaggi A
    J Neuroimmunol; 1998 Feb; 82(1):5-12. PubMed ID: 9526840
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.